Human umbilical cord mesenchymal stem cells(Universitas Sriwijaya)

人脐带间充质干细胞（Universitas Sriwijaya)

Report date: 2023/01/12 15:40:55

Base Information

Drug NameHuman umbilical cord mesenchymal stem cells(Universitas Sriwijaya)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsLiver CirrhosisOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversitas Sriwijaya
China Registration ClassN/A

Develop Information

Active CompaniesUniversitas SriwijayaAsia Cell Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A